Cargando…
An oncolytic herpes virus expressing E-cadherin resists NK cell clearance and improves viral spread and glioblastoma virotherapy
An engineered oncolytic herpes virus shows enhanced intratumoral spread, resistance to NK cell clearance and improved efficacy against brain cancer in mice.
Autores principales: | Xu, Bo, Ma, Rui, Russell, Luke, Yoo, Ji Young, Han, Jianfeng, Cui, Hanwei, Yi, Ping, Zhang, Jianying, Nakashima, Hiroshi, Dai, Hongsheng, Chiocca, E. Antonio, Kaur, Balveen, Caligiuri, Michael A, Yu, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535376/ https://www.ncbi.nlm.nih.gov/pubmed/30475349 http://dx.doi.org/10.1038/nbt.4302 |
Ejemplares similares
-
Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy
por: Alvarez-Breckenridge, Christopher A., et al.
Publicado: (2013) -
Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy
por: Nakashima, Hiroshi, et al.
Publicado: (2015) -
A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases
por: Chen, Xilin, et al.
Publicado: (2016) -
An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma
por: Xu, Bo, et al.
Publicado: (2021) -
Replication and Spread of Oncolytic Herpes Simplex Virus in Solid Tumors
por: Hong, Bangxing, et al.
Publicado: (2022)